The TOLL of inflammation in multiple myeloma

被引：1
|
作者：
Bell, Jessica K. [1 ]
机构：
[1] Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Richmond, VA 23284 USA
来源：
CANCER BIOLOGY & THERAPY | 2011年 / 11卷 / 01期
关键词：
multiple myeloma; inflammation; toll-like receptor 4; lipopolysaccharide; interleukin-18; STRUCTURAL BASIS; IFN-BETA; RECEPTORS; CELLS; RECOGNITION; EXPRESSION; PROLIFERATION; SURVIVAL; PATHWAY; CANCER;
D O I：
10.4161/cbt.11.1.14153
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：68 / 70
页数：3
相关论文
共 50 条
  • [41] Ruxolitinib Regulates the Autophagy Machinery in Multiple Myeloma Cells
    Kusoglu, Alican
    Bagca, Bakiye G.
    Ay, Neslihan P. O.
    Saydam, Guray
    Avci, Cigir B.
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2020, 20 (18) : 2316 - 2323
  • [42] Fucoidan inhibits angiogenesis induced by multiple myeloma cells
    Liu, Fen
    Luo, Guoping
    Xiao, Qing
    Chen, Liping
    Luo, Xiaohua
    Lv, Jinglong
    Chen, Lixue
    ONCOLOGY REPORTS, 2016, 36 (04) : 1963 - 1972
  • [43] Chromosomal instability and acquired drug resistance in multiple myeloma
    Wang, Wang
    Zhang, Yi
    Chen, Ruini
    Tian, Zhidan
    Zhai, Yongpin
    Janz, Siegfried
    Gu, Chunyan
    Yang, Ye
    ONCOTARGET, 2017, 8 (44) : 78234 - 78244
  • [44] Roles and Modalities of Ectonucleotidases in Remodeling the Multiple Myeloma Niche
    Chillemi, Antonella
    Quarona, Valeria
    Antonioli, Luca
    Ferrari, Davide
    Horenstein, Alberto L.
    Malavasi, Fabio
    FRONTIERS IN IMMUNOLOGY, 2017, 8
  • [45] Toll-Like Receptor (TLR)-1/2 Triggering of Multiple Myeloma Cells Modulates Their Adhesion to Bone Marrow Stromal Cells and Enhances Bortezomib-Induced Apoptosis
    Abdi, Jahangir
    Mutis, Tuna
    Garssen, Johan
    Redegeld, Frank A.
    PLOS ONE, 2014, 9 (05):
  • [46] Lymphocyte profile in peripheral blood of patients with multiple myeloma
    Dekojova, Tereza
    Gmucova, Hana
    Maceckova, Diana
    Klieber, Robin
    Ostasov, Pavel
    Leba, Martin
    Vlas, Tomas
    Jungova, Alexandra
    Caputo, Valentina S.
    Cedikova, Miroslava
    Lysak, Daniel
    Jindra, Pavel
    Holubova, Monika
    ANNALS OF HEMATOLOGY, 2024, : 5615 - 5625
  • [47] miR-218 contributes to drug resistance in multiple myeloma via targeting LRRC28
    Chen, Haifei
    Cao, Weiling
    Chen, Jiao
    Liu, Danbo
    Zhou, Lingyun
    Du, Fang
    Zhu, Feiqi
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2021, 122 (3-4) : 305 - 314
  • [48] Stimulation of Toll-like receptor-1/2 combined with Velcade increases cytotoxicity to human multiple myeloma cells
    Abdi, J.
    Mutis, T.
    Garssen, J.
    Redegeld, F.
    BLOOD CANCER JOURNAL, 2013, 3 : e119 - e119
  • [49] Angiogenic cytokines profile in smoldering multiple myeloma: No difference compared to MGUS but altered compared to symptomatic myeloma
    Gkotzamanidou, Maria
    Christoulas, Dimitrios
    Souliotis, Vassilis L.
    Papatheodorou, Athanasios
    Dimopoulos, Meletios A.
    Terpos, Evangelos
    MEDICAL SCIENCE MONITOR, 2013, 19
  • [50] Knockdown of DEPTOR inhibits cell proliferation and increases chemosensitivity to melphalan in human multiple myeloma RPMI-8226 cells via inhibiting PI3K/AKT activity
    Zhang, Hao-Ran
    Chen, Jun-Min
    Zeng, Zhi-Yong
    Que, Wen-Zhong
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2013, 41 (03) : 584 - 595
12345